Funder
Mateon Therapeutics, Inc.
Novartis
Cancer Treatment and Research Trust
Christie Foundation NHS Trust
Cancer Research UK
Manchester Experimental Cancer Medicine Centre and Clinical Research Facility
NIHR Biomedical Research Centre
South London and Maudsley NHS Foundation Trust
King's College London
NIHR Evaluation, Trials and Studies Coordinating Centre
Subject
Obstetrics and Gynecology,Oncology
Reference29 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018
2. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J. Clin. Oncol.,2012
3. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N. Engl. J. Med.,2011
4. A phase 3 trial of bevacizumab in ovarian cancer;Perren;N. Engl. J. Med.,2011
5. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial;Pujade-Lauraine;J. Clin. Oncol.,2014
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献